This study demonstrated the important roles of the CXCL10/CXCR3, JAK/STAT3 and NGF/TrKA pathways in neuroinflammation and pain in chronic prostatitis, which provided novel therapeutic targets for pain management in chronic prostatitis. This evidence concerns the gene CXCR3 and chronic prostatitis.